Literature DB >> 20013093

First results of the federal quality assurance group ("Arztliche Stelle") in radiotherapy in Baden-Württemberg: part 2.

Hans Hawighorst1, Frederik Wenz, Norbert Hodapp, Gerd Becker.   

Abstract

PURPOSE: Part 2 of this study presents the results of the clinical audits of the "Arztliche Stelle" (AS) concerning process quality in the radiation therapy units in Baden-Württemberg, Germany.
MATERIAL AND METHODS: The process quality of nine main test groups (laws, organizations, technical equipment, GMP [Good Medical Practice] principles, radiotherapy, radiation procedure, follow-up, discharge report, physics) were questioned by the AS commission and evaluated in a four-stage classification (1-4; none to grave deficiencies).
RESULTS: In 18 institutes (81%), the medical and physical-technical inspection, including radiation protection for patients and staff, revealed very high to high quality, safe treatment commensurate with current standards was guaranteed once the suggestions for improvement given by the experts had been implemented. In four institutes (18%), the inspection showed a still satisfactory quality but a shorter period for reinspection was recommended. The most frequent comments/deficiencies were found in staff structures (32%), in continuous education/training for staff (32%), in informed patient consent (41%), follow-up (45%), and/or a unclearly formulated discharge report for the referring physicians (45%).
CONCLUSION: The medical and physical-technical examination of radiation treatment in the vast majority (81%) of the radiation therapy institutes in Baden-Württemberg showed a very high or high quality. Most of the comments and deficiencies concerned the sector of systematic continued training for staff, giving clear explanations to patients, structured follow-up, and the state of the medical discharge reports. These deficiencies, however, do not represent any immediate danger to the patient through any deficiencies in therapy. The experience gained by the AS could act as a model for quality improvement and could also be transmitted to other medical sectors to retain quality standards. The various specialist associations are called upon to gradually adopt the suggestions for quality improvements which are based on concrete as-is analyses by steadily aligning practice with theory. This would enable the steadily rising demands of quality assurance to be sustainably implemented through practicable models.

Entities:  

Mesh:

Year:  2009        PMID: 20013093     DOI: 10.1007/s00066-009-9972-8

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN: 0179-7158            Impact factor:   3.621


  6 in total

1.  Linearity of the dose monitor system at low monitor units.

Authors:  Peter Mohr; Sabrina Brieger; Jürgen Stahl; Gerlo Witucki
Journal:  Strahlenther Onkol       Date:  2007-06       Impact factor: 3.621

2.  Quality of training in radiation oncology in Germany. Results of a 2006 survey.

Authors:  Robert Semrau; Katja Hansemann; Markus Adam; Nicolaus Andratschke; Thomas Brunner; Frank Heinzelmann; Guido Hildebrandt; Dirk Vordermark; Daniel Zips
Journal:  Strahlenther Onkol       Date:  2008-05       Impact factor: 3.621

3.  [The RTOG/EORTC classification criteria for early and late radiation reactions].

Authors:  T Herrmann; A Knorr; K Dörner
Journal:  Radiobiol Radiother (Berl)       Date:  1987

4.  EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale.

Authors:  J J Pavy; J Denekamp; J Letschert; B Littbrand; F Mornex; J Bernier; D Gonzales-Gonzales; J C Horiot; M Bolla; H Bartelink
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

5.  [First results of the federal quality assurance group ("Arztliche Stelle") in radiotherapy in baden-württemberg: part 1].

Authors:  Hans Hawighorst; Gerd Becker; Norbert Hodapp; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-08-04       Impact factor: 3.621

6.  Improving dose homogeneity in large breasts by IMRT: efficacy and dosimetric accuracy of different techniques.

Authors:  Yasser Abo-Madyan; Martin Polednik; Angelika Rahn; Frank Schneider; Barbara Dobler; Frederik Wenz; Frank Lohr
Journal:  Strahlenther Onkol       Date:  2008-02       Impact factor: 3.621

  6 in total
  2 in total

1.  Pretreatment verification of dose calculation and delivery by means of measurements with PLEXITOM™ phantom.

Authors:  Paweł Wołowiec; Paweł Kukołowicz; Krzysztof Lis
Journal:  Rep Pract Oncol Radiother       Date:  2013-02-04

2.  [Survey of potential improvements during the course of the radiotherapy treatment--a patient questionnaire].

Authors:  Felix Momm; David Jooss; Carola J Xander; Sonja Adebahr; Viola Duncker-Rohr; Felix Heinemann; Simon Kirste; Marc-Benjamin Messmer; Anca-Ligia Grosu; Gerhild Becker
Journal:  Strahlenther Onkol       Date:  2011-10-28       Impact factor: 3.621

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.